Investor directory

HBM Healthcare Investments

VC fundZug, Switzerlandhbmhealthcare.com

HBM Healthcare Investments targets high-value healthcare companies with advanced products, focusing on private and public investments.

What they invest in

Geographies

global

The facts

Typical cheque
€9M – €30M
Headquarters
Zug, Switzerland
Founded
2001

More portfolio companies

FreenomeEverest Medicines (HKG: 01952)CORXEL PharmaceuticalsDamora Therapeutics (Biotechnology) (NAS: DMRA)Legend Biotech USA (NAS: LEGN)OneSource Specialty Pharma (BOM: 544292)AmbrxNuance PharmaIgnis TherapeuticsValoInstil Bio (NAS: TIL)Harbour BioMed (HKG: 02142)ALX Oncology (NAS: ALXO)Visen Pharmaceuticals (HKG: 02561)Alumis. (NAS: ALMS)iTeos TherapeuticsSpringWorks TherapeuticsRubius TherapeuticsBioInvent International (STO: BINV)Parabilis Medicines (NAS: PBLS)Chinook TherapeuticsCurevo VaccineADARx PharmaceuticalsBiohaven (NYS: BHVN)

and 25 more

Recent rounds

  • Crystalys Therapeutics

    $130 millionSeries BHealthTech

    Frazier Life SciencesleadHBM Healthcare InvestmentsSoleus CapitalCormorant Asset ManagementTrails Edge Capital PartnersKCap Biotechnology Fund · +15 more in the source

    United Statesprnewswire.com

Rounds HBM Healthcare Investments took part in, as reported by the linked articles. See who else is investing right now.

Questions founders ask

How much does HBM Healthcare Investments typically invest?
HBM Healthcare Investments states a typical cheque of €9M – €30M.
Which stages does HBM Healthcare Investments invest in?
HBM Healthcare Investments invests at Growth, Series A, Series B and Seed.
Where is HBM Healthcare Investments based?
HBM Healthcare Investments is headquartered in Zug, Switzerland.

Does HBM Healthcare Investments fit your round?

In 30 minutes you'll know which funds matter for your round.

Request access

Search investors like this in Claude — no account, no sign-in. Open in Claude

Are you HBM Healthcare Investments? Tell us what to correct and we will update it — or ask us to remove the entry.